Identification of a biochemical difference between male and female human fibroblasts: Implications for the expression of duchenne muscular dystrophy

Michael H. Davis, Carlos N. Pato, Henry Grinvalsky, Eric Gruenstein

Research output: Contribution to journalArticlepeer-review

Abstract

The lysosomal enzyme dipeptidyl aminopeptidase-I (DAP-I) was reduced in Duchenne muscular dystrophy (DMD) fibroblasts to 30% of the level found in age- and sex-matched controls (p < 0.005). Structure-linked latency, defined as the increase in DAP-I activity caused by disruption of the lysosomal membrane, was also reduced in Duchenne fibroblasts to 70% of normal levels (p < 0.001). Duchenne carriers and age- and sexmatched control fibroblasts had similar DAP-I activities and latency. However, the similarity of normal and carrier female DAP-I activities was not due to elevation of the carrier female activities to levels similar to normal males, but rather to reduction of all female DAP-I activities to 30% of normal male levels (p < 0.001). This gave them comparable activities to those of the male DMD cells. One explanation for these unexpected results would require a modification of the genetics of DMD to that of a Y-influenced X-linked model.

Original languageEnglish (US)
Pages (from-to)951-957
Number of pages7
JournalNeurology
Volume32
Issue number9
DOIs
StatePublished - Sep 1982
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Identification of a biochemical difference between male and female human fibroblasts: Implications for the expression of duchenne muscular dystrophy'. Together they form a unique fingerprint.

Cite this